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ABSTRACT
According to the WHO, about 5 % of the world’s population suffers from disabling hearing loss. In 
people above the age of 65 the number is more than 30 %. Common effects of this condition are poor 
speech discrimination and impaired communication abilities. Patient surveys show that hearing loss 
often leads to a diminished quality of life.
The work presented in this thesis aims to evaluate and improve the performance of transplanted cells 
in vitro. Ultimately, we want to facilitate new connections between neurons of the brainstem (BS) 
and inner ear structures, or a hearing aid, with the help of transplanted cells. We predict that this will 
prove to be a feasible path to enhance the rehabilitation results for a selected group of patients with 
severe hearing disability.
We have developed an organotypic auditory cell culture model for the study of cell performance in 
vitro to help enhance cell transplantation performance in vivo. This model utilizes a BS slice inclu-
ding the cochlear nucleus to simulate an auditory target organ for transplanted cells. Here, we use this 
model to investigate new ways to improve existing transplantation protocols.
Paper I reports the effects of enriching a mouse boundary cap (BC) progenitor cell culture with the 
trophic factors inherent to a rat auditory BS slice conditioned medium (CM). The BS CM proved 
to have positive effects on the survival and differentiation of mouse BC cells in culture. We also re-
port the specific brain derived neurotrophic factor (BDNF) and glial-cell derived neurotrophic factor 
(GDNF) contents of BS CM and how this content fluctuates over time.
Paper II reports the effects on human neural progenitor cells (HNPCs) from the addition of a sur- 
face substrate presenting bioactive molecules and a specific neurotrophin content. The commercially 
available Corning® Matrigel® tested here, proved to enhance the survival of seeded dissociated HN-
PCs when evaluated after three weeks in culture. We also report on the differentiation characteristics 
of HNPCs and their axon forming capacity.
In Paper III we investigate the survival rate in vitro of progenitor cells transplanted at different 
differentiation time points. Here, neuroepithelial-like stem (NES) cells derived from human induced 
pluripotent stem cells (hiPSCs) was cultured in three groups, with cells at separate differentiation 
states (NES cells, neuroblasts and neurons of various maturity (NVM)). These specimens were cul- 
tured as a monoculture or in co-culture with a mouse auditory BS slice. Cells seeded as a mono-
culture, without a BS slice, displayed a considerable lower survival rate as compared to the co- 
cultured cells. We conclude that the seeded NES were quite dependent of the trophic support from the 
co-cultured BS slice. We speculate that NES cells are quite vulnerable to the trauma and stress 
involved in the seeding process, and particularly so when cultured in a more differentiated state. We 
also report on the differentiation characteristics of cells after culture as revealed by immuno- 
cytochemical staining, as well as their tendency to migrate towards the BS slice in co-culture.
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In Paper IV, we present the evaluation of a method to perform an electrophysiological activity assay 
of tissue specimens including the cochlear nucleus, cultured ad modum Stoppini. Here, we utilize 
the microelectrode array (MEA) platform with a modified protocol, to successfully record the endo- 
genous neural activity of auditory BS slices. Our results concur with the basic characteristics of 
previously reported electrical activity in brain tissue.
In conclusion, these studies report novel information that could not practically have been gathered 
in vivo without utilizing a significantly larger number of experimental animals. We present promi-
sing results on the utilization of CM and cell matrix additives, the possible improvement of time 
schemes for cell transplantation, extensive characterization of cells in differentiation and a new 
model for future functional evaluation of cells in interface-culture. These results help us to better 
comprehend the innate obstacles encountered when searching for a successful in vivo cell transplan-
tation paradigm to the impaired auditory nervous system.
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INTRODUCTION
With the combined work presented here, we bring recent advances in cell transplantation research 
closer to benefitting the hearing-impaired patient. We study and evaluate the in vitro performance of 
cells in culture and the methods by which these evaluations are performed, resulting in novel infor-
mation that can be utilized in future hearing rehabilitation research.
BACKGROUND
Hearing
In normal hearing, sound begins as pressure variations in air which are funneled through the outer 
ear canal to its bottom, where the tympanic membrane resides. As these sound waves bounce off, the 
generated vibrations are transplanted via the middle ear ossicles into the inner ear. Here, the mecha-
nical stimuli affect the cochlear hair cells and is converted into neuronal signals. Now as electro- 
physiological signals, the sound information is relayed to the neuronal cells of the spiral ganglion in 
the center of the cochlea. From here they are sent via the auditory nerve to the second order neurons 
in the cochlear nucleus (CN) in the brainstem (BS) (Figure 1). From the BS, the sound information is 
forwarded to the central nervous system (CNS) where the electrophysiological signals translate into 
sound which is interpreted in the auditory cortex.
Figure 1. The human auditory system. Via the auricle, through the ear canal, sound funnels to the 
eardrum which anatomically separates the outer ear (yellow) from the middle ear (blue). Vibrations gene-
rated on to the eardrum are transplanted through the ossicles of the middle ear to the fluids of the inner 
ear (red). Here, these vibrations are transformed into electrical signals by hair-cells. Signals that are pas-
sed on to the spiral ganglion neurons and further through the cochlear nerve (orange) to the brainstem 
(grey). From here, the signals are further relayed to the central nervous system (CNS).
More than 5 % of the human population of the world, and 30 % of the people over 65 years of 
age, display a disabling hearing loss (WHO, 2018). This impairment is a result of qualitative and 
quantitative deterioration of different parts of the auditory system, and approximately half of the 
hearing-impaired patients need a hearing aid. Without aids, many patients will suffer from poor spe-
ech discrimination and impaired communication abilities. Patient surveys show that hearing loss 
often leads to a diminished quality of life, including extreme daytime fatigue, isolation, reduced 
social activity, sense of alienation and increased incidence of depression symptoms.
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In vitro research and hearing
For many patients, a modern hearing aid is a very practical device to accomplish a sufficient hearing 
rehabilitation. Unfortunately, less than 50 % of the patients in need of a hearing aid receive one. And 
for some patients, depending on their type of disability, other ways to rehabilitation is needed. If the 
middle ear structures are damaged from infection, trauma or genetic disorders, surgery may be a fea-
sible way to ameliorate the symptoms. If the inner ear organs are damaged from disease, medication 
or genetic disorders, the hearing can today sometimes be partly restored with the help of modern pro-
sthetics (i.e. a cochlear implant). It is not uncommon that a combination of surgery and hearing aid/
prosthesis is needed. But, even with modern advances in medicine and hearing aid technology, many 
patients suffer from inadequate hearing function due to the limitations of available methods, or simply 
because their disabilities are not accessible for rehabilitation. Investigations into how we can possibly 
aid these patients are now reaching into the areas of cell transplantation.
Since cell transplantation into patients always are precluded by thorough preclinical trials, all ethical 
protocols include mandatory studies in animals and studies in vitro, prior to clinical use. It is today, 
for obvious ethical reasons, required to utilize cell cultures when possible to minimize the use of 
experimental animals. It is also evident that there are many detailed investigations of cell per- 
formance that are not only feasible, but also much more efficient in a controlled laboratory environ-
ment than within an in vivo framework.
Organotypic auditory cell culture model
Our group has extensive experience of cell culture work from many years of research. We have 
published results from both in vitro and in vivo experiments using a variety of different cells and ex-
perimental setups (Glavaski-Joksimovic et al., 2008; Glavaski-Joksimovic et al., 2009; Novozhilova, 
Olivius, Siratirakun, Lundberg, & Englund-Johansson, 2013; Palmgren, Jiao, Novozhilova, Stupp, & 
Olivius, 2012; Thonabulsombat, Johansson, Spenger, Ulfendahl, & Olivius, 2007).
To approach the auditory system in vitro, we have developed an organotypic auditory model using 
an adult mouse or rat donor. Our basic setting is comprised of a 300 µm thick BS slice including the 
CN and the proximal part of the auditory nerve. This is propagated as an interface-culture ad modum 
Stoppini on a semipermeable membrane (Stoppini, Buchs, & Muller, 1991), as a model of the host 
organ (i.e. target organ). A culture like this can be propagated for weeks and constitute a stable expe-
rimental platform. Our group has utilized this setting extensively to examine the performance of cells 
in mono- and co-culture.
Cell culture settings
The basic physiochemical requirements of cell culture (i.e. temperature, pH, osmotic pressure, 
O2 and CO2 tension) do not vary much between different setups. The physiological environment 
though, consisting of mediums to supply cells in culture with nutrients, hormones and growth factors, 
often differ between established protocols. The natural reason for this is that the mechanisms involved 
are not fully understood and there are no consent on what constitutes an optimal medium for a specific 
purpose. With recent advances, it has also become obvious that the composition of supporting trophic 
molecules in the culture medium is crucial for cell performance, particularly when it comes to the 
delicate culturing of stem and progenitor cells.
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Also the physical milieu has been subjected to alteration and evaluation. There are several products 
available designed to mimic the physical milieu at the transplantation site. Some of these products are 
designed for 2D surface culture applications, while others provide a more complicated 3D structure. 
Furthermore, the designs of bioactive molecules to modulate culture performance have been intro- 
duced as a variable. Altogether, these manipulations aim to construct an in vitro environment that has 
a greater chance of generating results that can be readily translated into similar results in vivo.
The microenvironment of cultured cells is determined by cell-cell interactions, matrix interactions 
and gas exchanges. The cells possibilities to interact in these capacities in culture is greatly influenced 
by the way the cells are seeded. There are three major preparations in which this can be performed. 
Either as a tissue specimen (e.g. slice of tissue), which commonly is 200-400 µm thick, as a sphere, 
which is the free-floating cell aggregate developed by suspended cells in a culture flask, or as a single 
cell preparation of dissociated cells.
Neurotrophins
Since researchers have started to look for the molecules responsible for the observed growth stimu-
lation of cells, the knowledge concerning these molecules has expanded and the efforts have been 
organized as new fields of biological science.
The group of molecules displaying a trophic effect on neurons are called neurotrophins. These 
include factors with different gene ancestors. One family of proteins that share a common gene 
ancestor (Leibrock et al., 1989)  and are essential to mammals is named Neurotrophins (NTs). These 
were the first neurotrophic factors described and they all play a vital role during neuronal development. 
It has been shown that NTs are instrumental in the regulation of neurons both centrally and 
peripherally. This group consist of nerve growth factor (NGF) (Cohen, Levi-Montalcini, & Hamburger, 
1954; Levi-Montalcini, 1987), brain-derived neurotrophic factor (BDNF) (Barde, Edgar, & Thoenen, 
1982), Neurotrophin 3 (NT-3) and Neurotrophin 4/5 (NT-4/5) (Lewin & Barde, 1996). They collec- 
tively ensure a suitable match of the neuronal density in their target organs (Lewin & Barde, 1996) 
and control cell fate, axonal growth and guidance, dendrite structure and pruning, synapse formation 
and synaptic plasticity (Huang et al., 2001; Kaplan & Miller, 2000; Lewin & Barde, 1996; Poo, 2001).
In addition to the NT’s, glial cell-derived neurotrophic factor (GDNF)  is shown to have trophic 
effects on developing (Lin, Doherty, Lile, Bektesh, & Collins, 1993) and adult midbrain dopamin-
ergic neurons (Lapchak, 1996). GDNF has also been reported to increase the survival and neurite 
growth of spiral ganglion neurons and thus play a vital role in development of the central auditory 
pathways and the inner ear (Euteneuer et al., 2013).
Conditioned medium
During the early development of the research field into neurotrophic factors, the concept of condi- 
tioned medium (CM) comprised a powerful tool to harvest substantial amounts of cell specific trophic 
molecules in. In short, the CM consists of culture medium collected after it has been used in a cell 
culture for 24-48 hours. Some nutrients in the medium are consumed during culture, but the medium 
is also enriched (conditioned) with the excreted secretome of the specific cell type in culture. This 
secretome contain serum proteins, extracellular matrix proteins, digestive enzymes and a low con-
centration of highly bioactive proteins. These bioactive proteins have been found to include growth 
factors, hormones, cytokines and extracellular matrix processing proteases. All of these are now 
documented to play key roles in regulation of cell differentiation and renewal (Skalnikova, Motlik, 
Gadher, & Kovarova, 2011).
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The CM was found to have trophic effect on cells in culture. Early on it was a common practice to 
supplement cell culture mediums with CM. Today, when we have gathered more detailed knowledge 
on what is required to successfully culture cells in vitro, we still find the use of CM to be an efficient 
supplement, even to modern culture mediums. 
Few CMs have previously been analyzed in detail. A CM from our utilized BS slice with CN is not 
one of them. As we have previously reported positive results from experimental cultures using BS 
CM, we predict that elucidating its contents and concentrations of trophic factors can lead to a better 
understanding of the mechanisms behind the results achieved utilizing CMs.
Alteration of physical milieu
Much efforts have been directed towards improving the physical milieu of cells in vitro. There are a 
number of conditions that are subject to recent advances and they show that small modulations to the 
culture environment can have large effects on cell performance. 
The in vitro milieu into which we transplant cells, needs to have similarities with that of the future 
transplantation site for comparative reasons. The culture milieu will naturally be drastically diffe-
rent in many ways to a transplantation site, but in some areas we can create a resemblance with the 
environment that the cells were intended for.
In standard cell culture protocols the specimens are either seeded in a fluid, or onto a glass or 
plastic surface. Since it is difficult for cells to develop in a suspension in general (with the exception 
of hematopoetic cells), the culture of free-floating cells are mostly used for propagation and bulk 
production of cells for later harvest and usage. The solid surface of culture vessels and cover slips 
is in many ways a more physiological option as it provides the mechanical support needed for all 
anchorage-dependent cells to thrive. To assist survival and migration, these surfaces are typically 
coated with attachment and adhesion proteins, such as collagen, laminin and fibronectin, or synthetic 
polymers as in Poly-D-Lysine.
In 1991, the already established interface-culture method was successfully introduced as a alternative 
to the existing methods for culture of nervous tissue explants (Stoppini et al., 1991). Compared to the 
avaible methods this greatly simplified protocols. The method utilize a transparent porous membrane 
for culture surface and does not require the use of a plasma clot to attach cell specimens. Cells are 
cultured in the interface between air and culture medium, and yield specimens that remain 1-4 layers 
thick charaterized by a well preserved organotypic organisation. This also resolved much of the glial 
scarring problems that was commonly noticed in cultures on  solid surfaces as a result of nutrient and 
oxygen deprivation in the areas furthest away from the medium (i.e. cell-vessel contact area).
Further, the development of surface coatings with molecules supplying a connective tissue like 
environment has advanced. The products that are available now also include specific bioactive 
domains that can be utilized to improve cell survival and differentiation. These products can be coated 
as thin layers (2D) or prepared as gels of different thicknesses supplying a 3D milieu. Cells seeded 
in 3D can benefit from the provived mechanical scaffold in their arrangement of molecules and such 
in vivo-like structural organization has been shown to enhance the survival of cells in culture 
14 15
(Webber et al., 2010). It can also improve their differentiation, morphological profiles and general 
functions. These products are often combined with different contents of trophic factors, providing 
several cell culture options to be utilized in experimental settings.
One example of scaffolding (utilized in Paper II) is the Corning® Matrigel®. This is a preparation 
extracted from a mouse sarcoma which is rich in extracellular matrix proteins. Due to the innate 
capacity of these cells to stimulate teratomas (Vaillant, Lindeman, & Visvader, 2011) they are not 
likely to be considered a preferred substances for clinical use. However, as a research tool these 
products can be very useful. They are often rich of substances that are well documented to benefit 
cells in culture. The Matrigel® (used here), contain laminin, collagen, entactin and a naturally provides 
a wide range of growth factors.
Cell transplantation
It is delicate work to identify a suitable donor cell type to serve as a substrate in a cell transplantation 
paradigm, much due to the fact that the specifics of a working cell transplantation protocol is not 
yet defined. And prioritizing research efforts is increasingly complicated as there is an ever growing 
number of potential donor cells available through commercial suppliers, as well as through research 
collaborations.
The autologous transplantation of cultured cells have been a tantalizing paradigm on the mind of 
many researchers ever since the discovery of adult neurogenesis (Altman & Das, 1965) as a product 
of the budding field of stem cell (SC) research (Becker, Mc, & Till, 1963). The SC was subsequently 
defined as a cell with intact capability to differentiate into cells of all three germ layers and to renew 
themselves through cell division. To a researcher involved in the field of cell transplantation, this 
constitutes a very plausible substrate for the regeneration or replacement of an impaired organ. 
Three types of stem cells
The embryonic stem cells (ESCs) are the ‘‘primitive (undifferentiated) cells derived from the early 
embryo that have the potential to become a wide variety of specialized cell types’’ (IOM, 2008). 
These cells can be found in humans (and most other mammals) during the first 4 cell divisions after 
conception (eventually a 16-cell morula)(Svendsen, 2008). After this, the cells of the budding 
embryo (blastocyst) start to differentiate down a regulatory pathway. This pathway is one-way and 
eventually render the cells specialized with less capacity to differentiate into other cells. It has been 
shown that the ESCs are very good candidates for usage in regenerative medicine (Nury, Neri, & 
Puceat, 2009).
The adult SC is “an undifferentiated cell found in a differentiated tissue that can renew itself and 
(with limitation) differentiate to yield the specialized cell types of the tissue from which it origina-
ted’’ (IOM, 2008). The existance of adult SCs were first documented in the spleen in 1963 (Becker 
et al., 1963), and has later been documented in many organs, e.g. brain (Lewis, 1968), bone marrow 
(Trentin, 1989) and skin (Toma, McKenzie, Bagli, & Miller, 2005). Adult SCs can be very useful for 
transplantation in degenerative diseases (Gogel, Gubernator, & Minger, 2011). These cells can quite 
easily be incorporated into host tissue, develop highly specialized functions and improve organ func-
tion (Lumelsky et al., 2001; Studer, Tabar, & McKay, 1998). 
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The induced pluripotent stem cell (iPSC) is derived from an adult cell by reprogramming and was 
first established in 2006 (Takahashi & Yamanaka, 2006). They are generated via the introduction of 
retroviral transcription of factors. Human iPSCs (hiPSCs) were first produced from skin fibroblasts 
and rendered pluripotent cells with similar features as ESCs (Takahashi et al., 2007). They do not 
raise ethical problems like the ESCs since hiPSC research does not destroy blastocysts or embryos. 
However, there are concerns that the introduction of retroviruses may cause cancer or deleterious 
mutations in the host (Hyun, Hochedlinger, Jaenisch, & Yamanaka, 2007).
Progenitor cells
The progenitor cells are more differentiated cells as compared to the SCs. These cells are still able 
to divide multiple times but have started their differentiation downstream (Petersen, Zou, Krauss, & 
Zhong, 2004). Studies have shown promising use of progenitor cells in myocardial neovasculariza-
tion treatment of ischemic disease (Kawamoto et al., 2001), CNS injury treatment (Nandoe Tewarie, 
Hurtado, Bartels, Grotenhuis, & Oudega, 2009), as well as in liver and acute kidney injury repair 
(Becherucci et al., 2009; Zhao, Ren, Zhu, & Han, 2009). Transplantation of neuronal precursor cells 
has led to replacement of damaged neurons in the adult CNS (Bjorklund & Lindvall, 2000). It has 
also been shown that transplanted progenitor cells can reduce the inhibitory gliosis and scarring that 
occurs as part of the healing process in the CNS following injury (Palmgren et al., 2012). 
The BC cells (utilized in paper I) comprise a source of multipotent sensory specified SCs that  has 
been shown to differentiate spontaneously into functionally diverse types of sensory neuronal 
(Hjerling-Leffler et al., 2005), and non-neuronal cell types (Aquino et al., 2006). They normally con-
stitute a source of neuronal and glial cells to the peripheral nervous system (Maro et al., 2004). 
Stem- and progenitor cell limitations
There are a few safety considerations inherent to the concept of using immature cells when generating 
cells for transplantation in vivo. Since both SCs and pluripotent cells have the ability to differentiate 
into various cell types, an in vivo transplantation will induce a potential risk of local teratoma forma-
tion or unwanted over-proliferation of cells resisting final differentiation. One way to reduce this risk 
is to efficiently pre-differentiatiate cells into the desired fate. Other ways to address this is to expose 
the cells to extrinsic cues (Chambers et al., 2009) or to intrinsic factors (Zhang et al., 2013). However, 
with increasing maturity at the time of transplant, the capabilities for a successful engraftment and 
integration of the transplanted cells may decline. To ensure cell type specificity and integration many 
replacement paradigms suggest transplantation at the stage of cell cycle exit (i.e. neuroblasts) as a 
reasonable compromise (Kriks et al., 2011; Liu et al., 2013). This will also reduce the risk of tumor 
formation even though an oncogenic genetic alteration can occur later in any cultured cell type.
Evaluation of cell performance in culture
It is possible to perform a palette of qualitative and quantitative evaluations of cell performance in 
vitro. Modalities that are routinely evaluated when studying cell performance include survival, dif-
ferentiation and integration. There are a multitude of technical methods available to facilitate these 
evaluations and a selection of them are commonly included in the basic inventory of any laboratory.
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To improve the performance of transplanted cells in vitro, we found it necessary to further evaluate 
the functional properties of neuronal cells in interface-culture. There are many established techni-
ques for the purpose of evaluating the electrical activity in cultured cells, but none of them suit the 
evaluation of cells cultured ad modum Stoppini.
The first reported method to facilitate evaluation of electrophysiological activity in cells was the 
voltage clamp technique (Hodgkin & Huxley, 1952). This later evolved into the still frequently 
utilized patch clamp technique (Neher and Sakmann, 1976; Sakmann and Neher, 1984). The use of 
these techniques has greatly benefitted the research community in ways of detecting electrical activity 
over cell membranes (subthreshold synaptic potentials, membrane oscillations and action potentials) 
and on whole complex cell networks (e.g. brain specimens).
MEA
During the 1980s to the early 1990s, the microelectrode array (MEA) technique was introduced 
(Novak & Wheeler, 1986). It is a technique that while still undergoing rapid development has 
matured in many ways into a standard laboratory assay to perform electrophysiological recordings on 
dissociated cells in culture, and on tissue specimens. 
The MEA technique is a powerful complimentary method to the earlier techniques, as it enables 
the user to measure extracellular field potentials, generated by actions potentials, over large are-
as determined by a fix pattern of electrodes (Panuccio, Colombi, & Chiappalone, 2018). These 
electrodes are mounted on plates that can serve as either a culture surface for dissociated cell cul- 
tures, or as a measurement fixture for acute recordings on tissue specimens. The known inter- 
electrode distance is crucial for advanced detailed analyses, as it facilitates an accurate pinpointing 
of any neuronal network interactions. Today, powerful algorithms are available to analyse recorded 
signals from MEA plates with the help of computational tools. This has led to many publications of 
advances into the understanding of brain development, the effects of pharmaceuticals and intricate 
mechanisms of neuronal disease (Ben-Ari, 2001; Katz & Shatz, 1996; Madhavan, Chao, & Potter, 
2007; Maeda, Robinson, & Kawana, 1995; van Pelt, Vajda, Wolters, Corner, & Ramakers, 2005; 
Wagenaar, Pine, & Potter, 2006; Yvert, Branchereau, & Meyrand, 2004). The advances in MEA- 
technology with refinement of the initial perforated MEA-plates (Boppart et al 1992), the advent 
of carbon nanotechnology (Greenbaum et al., 2009) and hyper-dense CMOS sensors (Jackel, Frey, 
Fiscella, Franke, & Hierlemann, 2012), are continously increasing the quality of the recorded data.
 
The present MEA technique protocols do not facilitate analyses of established interface-cultures 
ad modum Stoppini. These specimens will not survive when submerged in the recording media as 
commonly specified in experiment protocols. It is though, possible to perform acute recordings on 
similar tissue samples for short periods of time, but there has been no reports on the evaluation of 
electrophysiological activity in an auditory BS slice.
 
18 19
AIMS
The aim of this thesis is to investigate a set of auditory neuronal experiments to aid the evaluation of 
transplanted cells in vitro. We specifically:
Paper I. Evaluate the effects of BS CM on BC cell performance in culture, and if 
these effects possibly correlate with medium BDNF and GDNF content.
Paper II. Evaluate the effects on dissociated HNPC survival and differentiation in  
culture by the addition of a neurotrophic factor rich bioactive matrix  
coating to the culture surface.
Paper III. Characterize the performance of neuroepithelial-like stem cells seeded to 
culture at different states of differentiation.
Paper IV. Assess if the MEA technique can be utilized to perform evaluation of  
electrophysiological activity in an auditory BS slice interface-culture.
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Here we present the overall layout of the included experiments (Figure 2).
Figure 2. Schematics of experiment layout in papers I-IV. Four papers are included in this 
thesis. The papers address the choice of donor cells, aspects of culture settings, ways to analy-
ze results and the effect from co-culture with target cells (brainstem slice with cochlear nucleus). 
BC = boundary cap; CM = conditioned medium; BS = brainstem slice; HNPC = human neural 
progenitor cell; hiPSC = human induced pluripotent stem cell; NES = neuroepithelial-like stem 
(cell); NVM = neurons of various maturity; MEA = microelectrode array.
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MATERIAL AND METHODS
Animals (Papers I, III and IV)
Pregnant Sprague-Dawley rats (Scanbur) were obtained and their pups (P12-P14) were used for 
preparing BS slices (Paper I).
GFP-Tau mouse (Charles River Lab, Sulzfeld, Germany) embryos were used as donors for BC cell 
preparations (E11.5)(Paper I).
P9 neonatal C57BL/6 mice were used for preparing organotypic BS slices (Papers III and IV).
All work was done in accordance with local ethical guidelines and approved animal care pro- 
tocols N329/07, N3/11, N4/11 (Stockholms Norra Djurförsöksetiska nämnd)(Paper I) and C100115/15 
(Uppsala Djurförsöksetiska nämnd)(Papers III and IV).
Brainstem slices (Papers I, III and IV)
Animals were sacrificed by decapitation. Transverse sections (300 µm thick) of the excised brains 
were obtained using a McIIwain tissue chopper. Sections where chosen encompassing the proximal 
part of the cochlear nerve and the cochlear nucleus (CN) in the BS according to local anatomical 
landmarks (Herlenius et al., 2012; Thonabulsombat et al., 2007)(Figure 3). The size of each BS 
slice and amount of CN were approximated to be equal for all used slices. Slices were propagated as 
interface-cultures (Stoppini et al., 1991) on polyester membranes coated with 5 µg/ml poly-D-lysine 
hydrobromide and 10 µg/ml laminin. The culture medium was changed on the day after preparation 
of slices, followed by every other day thru the culture period.
Transplanted cells (Papers I-III)
Boundary Cap (BC) cells were isolated as previously described (Hjerling-Leffler et al., 2005). Briefly, 
GFP-Tau mouse (E11.5) dorsal root ganglions (DRGs) were dissected. Following dissociation using 
1 mg/ml Collagenase/Dispase the cells were plated. From the DRG cell culture BC sphere formations 
could be observed within two weeks of culture. BC spheres expressing GFP were selected after 2–3 
passages for use in protocols (Paper I).
The HNPCs used were originally established by L Wahlberg, Å Seiger, and now kindly provided by 
by Prof. A. Björklund. The cell line was derived from human embryonic 9-week post conception 
forebrain and perpetually continued as sphere culture. Spheres were seeded following dissociation 
(Paper II).
Figure 3. Bright-field picture of a brainstem slice. 
CN = cochlear nucleus. Scale bar = 500µm.
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The long-term self-renewing NES cells used here were derived from a hiPSC line established by 
standard retroviral transduction (Falk et al., 2012). The continual propagation of stem/progenitor 
cells were maintained as monolayers in poly-L-ornithine and laminin coated flasks. The density of 
seeded cells were 40 000 cells/cm2 and split every 2-3 days 1:3 to maintain a high density. With the 
planned medium changes adjusted to be performed every other day, along with an increased laminin 
concentration when coating, the NES cells begin to differentiate into subtypes of cells further down 
the neuronal lineage. This starts 4-5 days’ after bFGF/EGF growth factor withdrawal and render 
neuroblasts after 5-7 days, and a group of neurons of various maturity (NVM) after 2 weeks of culture 
(Paper III).
Mediums utilized (Papers I-IV)
A wide range of mediums were utilized in the preparation of cultures, experiments and analyses. 
For reference purposes, we here provide their names, contents and in which paper they were utilized 
(Table 1).
Conditioned medium (Paper I)
Medium was collected from rat BS slice monocultures every two to three days. To produce BS CM 
this was filtered and mixed with equal amounts of fresh medium (here BC medium) and pooled into 
one solution which was named BS conditioned culture medium. We included medium collected over 
a three-week period.
Two groups of CM with different amounts of BS slices were prepared, one with one slice and another 
with two slices per well. 
Three mediums where prepared for the mono- and co-culture experiment groups: BC medium (stan-
dard protocol); propagation medium (BC medium with added factors); BC conditioned culture medi-
um (propagation medium with BS CM).
Matrigel® (Paper II)
Cover glasses were coated with a thin preparation of Corning® Matrigel® matrix gel according to 
supplier instructions (50 µl/cm2) and placed on the bottom of culture wells.
Immunocytochemistry (Papers I, II and III)
The cultures were fixed in 4 % paraformaldehyde (PFA) in PBS (pH 7.4) for 1 hour at room tempera-
ture (RT). After 5X wash they were treated with ice-cold 20 % methanol in PBS for 5 minutes. After 
3X wash the tissues were treated with 0.5 % Triton-X in PBS overnight at 4 °C for permeabilization. 
After another 3X wash the specimen were incubated with 20 % BSA in PBS blocking solution for 
12 hours at 4 ºC. Then the incubation with primary antibodies started. The specimens were incubated 
with primary antibodies (Table 2) diluted in 5 % BSA in PBS overnight. After 4X wash the primary 
antibody-antigen complexes were visualized with secondary antibodies by incubation for 4 hours 
followed by a 4X wash. Staining specificity was confirmed by omission of the primary antibody. 
4´,6-Diamidino-2-phenylindole (DAPI) nuclear stain (10 µg/ml) was introduced before the final 4X 
wash of specimens.
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Table 1. Mediums utilized in cultures.
Medium Content Used in paper no.
Dissection medium HBSS, glucose 20 %, antibiotic-antimycotic 1 %. I, III, IV
Boundary cap (BC) medium Neurobasal medium, N2 1 %, B27 1 %. I
Propagation medium/ 
boundary cap (BC) medium
Neurobasal medium, N2 1 %, B27 1 %, epidermal 
growth factor (EGF) 20 ng/ml, basic fibroblast growth 
factor (bFGF) 20 ng/ml.
I
Brainstem (BS) medium/  
brainstem (BS) culture 
medium
High glucose DMEM, HBSS 30 %, glucose 6.5 g/l,  
25 mM HEPES, fetal bovine serum (FBS) 10 %,  
antibiotic-antimycotic 1 %.
I, III, IV
Brainstem (BS) conditioned 
culture medium
Medium collected from brainstem (BS) culture 50 %, 
propagation medium (Neurobasal medium, N2 1 %, 
B27 1 %, epidermal growth factor (EGF) 20 ng/ml, basic 
fibroblast growth factor (bFGF) 20 ng/ml) 50 %.
I
Brainstem conditioned  
medium (BS CM)
Medium collected from brainstem (BS) culture. I
Culture medium DMEM-F12, L-Glutamine 2.0 mM, glucose 6.5 g/l,  
N2 1 %, heparin 2.0 µg/ml, human basic fibroblast 
growth factor (hbFGF) 20 ng/ml, human epidermal 
growth factor (hEGF) 20 ng/ml, human leukaemia  
inhibitory factor (hLIF) 20 ng/ml.
II
Differentiation medium (DM) DMEM-F12, L-Glutamine 2.0 mM, glucose 6.5 g/l, N2 
1 %, heparin 2.0 µg/ml, human basic fibroblast growth 
factor (hbFGF) 20 ng/ml, human epidermal growth 
factor (hEGF) 20 ng/ml, human leukaemia inhibitory 
factor (hLIF) 20 ng/ml, fetal bovine serum (FBS) 10 %.
II
Culture medium/NES  
medium
DMEM/F12-GlutaMAX medium, N2 1 %, B27 0.1 %,  
penicillin-streptomycin 1 %, basic fibroblast growth 
factor (bFGF) 10 ng/ml, epidermal growth factor (EGF) 
10 ng/ml.
III
Neuroepithelial-like stem cell 
(NES) differentiation medium
DMEM/F12-GlutaMAX medium, N2 1 %, B27 1 %,  
penicillin-streptomycin 1 %.
III
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Table 2. Primary antibodies used in Papers I-IV.
Primary antibody Target Dilution Human 
specific
Utilized in 
paper no.
β-III tubulin (TUJ1) A structural protein found almost exclusively 
in neurons, a major constituent of micro- 
tubules.
1:200 no I, II, III
DCX A microtubule-associated protein expressed 
in developing neurons. 
1:200 no II, III
GFAP An intermediate filament protein type III found 
in astrocytes and other glia.
1:500 yes II, III
Human cytoplasmic 
marker
A cytoplasmic protein of human cells. 1:500 yes III
Human nuclei  
marker
The Ku80 protein located in the nucleus of 
human cells.
1:50 yes III
Ki67 General proliferation markers. 1:200 no III
MAP2 A microtubule-associated protein involved 
in microtubule assembly and in determining 
dendritic shape during the neuronal develop-
ment.
1:200 no II, III
Musashi A molecule that plays a role in the main- 
tenance of the stem cell state, selectively  
expressed in neural progenitor cells, including 
neural stem cells.
1:200 no III
Nestin A type VI intermediate filament expressed in 
the neuronal precursor and developing cells.
1:500 yes II, III
NeuN A protein expressed in post-mitotic maturing 
neuronal nuclei.
1:200 yes III
NF heavy chain Type IV intermediate filament, comprise  
axoskeleton and functionally maintain  
neuronal caliber.
1:1000 no III
OCT2 A marker for undifferentiated stem cells 1:500 no II
Peripherin A marker of neuronal development that is 
expressed concomitantly with axonal growth 
following axonal differentiation of sensory 
neurons.
A:500 no I
SOX2 A pluripotency transcription factor that plays a 
central role in the maintenance of stemness.
1:200 no III
SSEA-1 A negative surface marker for human  
undifferentiated stem cells, upregulated with 
differentiation.
1:300 yes III
SV2 A glycoprotein maintaining the readily  
releasable pool of secretory vesicles in neural 
and endocrine cells.
1:1000 no II
Synapsin 1 A phosphoprotein specific for neuronal  
synapses of the CNS and PNS.
1:1000 no II
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Image analysis (Papers I, II and III)
Photomicrography in combination with immunofluorescence is a powerful method for qualitative 
assessment and quantification of survival, differentiation and migration. Results are saved as pictures 
for visual evaluation and objective quantification.
Evaluation of migration (Paper I)
The specimen transplant area was divided into quadrants with the center of the BC cell transplant 
after fixation as origo. The total number of identified neurons with axonal growth in the absolute 
vicinity of the transplant was quantified at 100x magnification. Care was taken to blind the group 
affiliation and orientation of the transplants on the slide. The cells found in the quadrant encompas-
sing the hiatus between the transplanted cells and the BS slice were accounted for as attracted. The 
data are presented as a percentage of neurons in the attracted quadrant, out of the total number of 
neurons in the transplant area. This was presented separately for each experimental group.
Evaluation of axonal length (Paper I)
Axonal length was measured with a calibrated freehand line drawn along the axon of every selected 
cell. This was performed utilizing the drawing tool in ZEN software (blue edition).
Automated 2D analyses (Paper III)
An automated cell identification and quantification process was utilized to collect the vast data avai-
lable from the recorded material in paper III. Establishing the fully automated cell analysis was done 
with the kind support from Department of Information Technology at Uppsala University. Here, we 
report analyses from a total of 412 206 characterized cell profiles, utilizing this method.
In brief, the cell quantification was performed using CellProfiler cell image analysis software 
(Carpenter et al., 2006) and the scoring of phenotypes by machine learning was done using Cell- 
Profiler Analyst software (Jones et al., 2009). A first pipeline, Preprocess, was used on a reference 
picture set to generate basic data identifying the nuclei and the cytoplasm (Figure 4 and 5). This data 
was then used in CellProfiler Analyst to generate rules to facilitate the automatized quantification of 
positive cell profiles. These rules were utilized in the second pipeline, Classifier, to analyze all pictu-
res of a specific staining (Figure 5). To avoid confounders, all parameters in the analysis methods 
within the pipelines analyzing each group were kept identical.
ELISA (Paper I)
The ELISA method was utilized to characterize the specific contents of BS CM. BDNF and GDNF 
levels were assayed with ELISA kit reagents (Abnova Corporation). Culture medium samples were 
added in duplicates in individual pre-coated wells of a 96 well plate (Figure 6) and incubated for 90 
minutes. The plates were then emptied and blotted. 100 μl of biotinylated anti-rat antibody working 
solution was added and incubated for 60 minutes. After washing, 100 μl of ABC working solution 
was added and incubated for 30 minutes. After another washing, 90 μl of color developing agent 
was added and the contents were incubated in the dark for about 20 – 25 minutes. This was all done 
according to protocols provided by the supplier. Evaluation of the optical density were read at 450 
nm.
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Figure 4. A sample picture ren-
dered by CellProfiler software 
showing estimated cell marker 
boundaries. Shown here is an  
example of how the CellProfiler and 
Cell-Profiler Analyst software define 
the nuclei (DAPI, blue profiles with 
blue borders) and the cytoplasm 
(Ki67, red profiles with red borders) 
borders in a sample picture.
Figure 5. A schematic figure 
showing the process of automated 
cell profile evaluation utilizing the 
CellProfiler and CellProfiler Ana-
lyst softwares.
Figure 6. A 96 well ELISA kit plate. BS CM samples were 
analyzed individually in pre-coated wells.
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MEA (Papers IV)
All electrophysiological recordings of spontaneous activity were performed utilizing a  MEA 1060 amp- 
lifier (Multichannel systems, MCS) on a MEA 60MEA200/30iR plate (200 µm electrode spacing and 
30 µm electrode diameter) with plastic ring (Figure 7A).
A membrane insert containing one BS slice specimen was cut out with a scalpel and mounted 
face-down on the MEA plate. A Harp slice grid (ALA Scientific Instruments) was used to keep 
specimen in stable contact with the recording area (Figure 7B). The recordings started immediately 
after the slice had been mounted on the plate (Figure 7C). The data was continuously recorded at 
a sampling rate of 20 kHz for 30 minutes. Data acquisitions and analyses were performed using 
either MC_Rack software (V 4.6.2) or Multi Channel Suite software (Multi Channel DataManager V 
1.10.1) from Multi Channel Systems (MCS).
Statistics (Papers I, II and III)
Where applicable, all results were expressed as mean ± standard error of the mean (SEM). The values 
in control and experimental groups were compared by one-way ANOVA test followed by post hoc 
Tukey’s multiple comparison test. Differences of P≤0.05 were considered statistically significant. 
Figure 7. (A) A MEA plate with a plastic ring for the cell culture. (B) A Harp slice grid to hold speci-
men in place. (ALA scientific instruments). (C) Schematic picture of a mounted BS slice in the well 
of a 60-electrode MEA plate (left)(• marking electrode positions). Bright-fielded picture of a BS slice 
after 21 days of culture ad modum Stoppini, cut out and mounted face down on a MEA plate (right, 
with a Harp slice grid on top). BS = brainstem slice; Scale bar =500 µm.
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RESULTS
Paper I
Here we study the neurotrophin content in BS CM and its effects on BC cells. Two groups of mediums 
were evaluated for their BDNF and GDNF contents, one with one BS slice per well and another with 
two BS slices per well. BS medium was used as control. To evaluate the BS CM effects on BC cells 
we performed monocultures and co-cultures with BS slice, ad modum Stoppini, in three different 
mediums: BC medium, propagation medium and BS conditioned culture medium.
BDNF and GDNF analyses
BDNF-levels in standard BS medium were on average 37 ± 18 pg/ml. BDNF-levels in BS 
CM were on average 40 pg/ml in the one slice setting, and 62 pg/ml in the two-slice setting. 
GDNF-levels in BS medium were on average 79 ± 32 pg/ml. On average, the level of GDNF in BS 
CM was 66 pg/ml in the one slice setting and 90 pg/ml in the two-slice setting.
The BS CM levels of both BDNF and GDNF showed increments that also varied over time. A biphas-
ic release pattern was noticed (BDNF in days 5 and 15; GDNF days 3 and 12) in the BS CM collected 
from cultures with two slices (Figure 8).
Figure 8. Relative fold of BDNF and GDNF content in brainstem (BS) conditioned medium (CM). Two 
groups of BS CM preparation from 3 weeks of culture (one slice per well and two slices per well). ELISA 
analysis is shown as relative fold of BDNF (left) and GDNF (right) content in BS CM as compared to stan-
dard BS medium levels (=1). A biphasic pattern over time is noted (BDNF statistically significant). aP < 0.05, 
compared to 1 slice BS medium; bP < 0.05, compared to 2 slice BS medium.
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Analyses of BC cell monoculture
In BC medium, cells developed peripherin-positive neurite processes, but after six days of culture 
they already displayed abundant cell death. In propagation and BS conditioned culture medium the 
cell survival was high (Table 3). In propagation medium, the cells illustrated peripherin-negative 
cells, indicating lack of differentiation towards a neuronal fate (Table 3). In BS conditioned culture 
medium, the BC cells illustrated peripherin-positive neurite outgrowths within five days of culture 
and they maintained their strong peripherin expression during the entire three-weeks (Table 3).
Table 3. Survival and peripherin expression of mouse BC cell monocultures in three different mediums.
BC monoculture Survival Peripherin staining
BC medium <6d +
Propagation medium >3w -
BS conditioned culture medium >3w +
Analyses of BC cells in auditory BS slice co-culture
In co-culture with a BS slice, BC cells in BC medium and propagation medium did not survive for 
more than two weeks, whereas in BS conditioned culture medium BC cells were still propagating at 
the three weeks’ termination point (Table 4).
Signs of differentiation in BS conditioned culture medium was prominent as compared to the 
co-cultures in BC medium and propagation medium. Directional growth of axons from the differen- 
tiated BC cells towards the BS was seen in all three co-culture groups (Table 4), but the unidirectional 
growth towards the BS co-cultures in propagation medium and BS conditioned culture medium was 
stronger (Table 4).
Table 4. Survival, peripherin expression and attraction of mouse BC cell  co-culture with rat BS slice in 
three different mediums.
Co-culture Survival Peripherin staining Attraction
BC medium (n=13) 2w - 53% ±11
Propagation medium (n=12) 2w - 72% ±11
BS conditioned culture medium (n=3) >3w + 66% ±13
Paper II
Here we examine the effect of a hydrogel matrix coating on the survival of cells in surface culture. 
The experimental setup included two groups. Human neural progenitor cells (HNPCs) seeded as 
dissociated sphere cultures on Matrigel® coated coverslips, or on Matrigel® uncoated coverslips (stan-
dard Laminin coated). Cell differentiation was also studied using immunocytochemistry.
Survival of HNPCs
For quantification of surviving HNPCs in dissociated sphere culture (DSC) intact DAPI positive 
nuclei profiles were counted after three weeks. The experimental group displayed abundant survival 
with a high ratio of DAPI positive nuclei to seeded cells (99 % ± 5 %; Figure 9). The control group 
cultured on Matrigel® uncoated coverslips showed a low survival rate with only few intact nuclei to 
seeded cells (1,5 % ± 0,2 %; Figure 9).
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Expression of progenitor markers
To identify cells with immature profiles we did immunocytochemical analyses with nestin, a marker 
for stem/progenitor cells, and OCT2, a marker for undifferentiated SCs. The results illustrate that 
despite the high HNPC survival in the experimental group (Figure 9), nestin and OCT2 showed zero 
positive profiles, illustrating strong cell differentiation. The same results were found in the control 
group with zero positive profiles from nestin and OCT2 staining.
Expression of neuronal and glial markers
β-III tubulin and GFAP
The fate of the HNPCs in DSC was observed using the neuronal marker β-III tubulin that is almost 
exclusively found in neurons, and GFAP, a intermediate filament protein type III found in astrocytes 
and other glia. Most surviving cells grown on Matrigel® expressed β-III tubulin (60 % ± 5 %; Figu-
res 10 and 11) indicating the onset of differentiation down the neuronal lineage. There was also a 
substantial portion of the cells expressing GFAP (25 % ± 3 %; Figures 10 and 11). A number of cells 
(15 % ± 3 %) co-expressed β-III tubulin and GFAP (Figures 10-11).
 
Figure 9. Evaluation of the survival of dissociated sphere cultures 
(DSC) on Matrigel® (MG) coated coverslips. The number of intact cell 
profiles in the group cultured on Matrigel® coated coverslips after three 
weeks in culture were 99 % ± 5 %, and in the control group 1,5 % ± 0,2 %, 
as compared to the original amount of seeded cells. * indicates p < 0.05.
Figure. 10. Percentage of HNPCs in dissociated sphere cultures 
(DSC) expressing β-III tubulin and GFAP on Matrigel® (MG) coated or 
Matrigel® uncoated coverslips. HNPCs on Matrigel® coated coverslips 
showed signs of acquiring a neuronal properties with β-III tubulin positive 
profiles (60 % ± 5 %). Also, 25 % ± 3 % of the cultured cells expressed 
GFAP staining illustrating glial properties. A marked co-expression of β-III 
tubulin and GFAP (15 % ± 3 %) was also noted. The control group, not 
cultured on Matrigel® coated coverslips, showed no staining (here survival 
was close to zero). * indicates p < 0.05.
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MAP2 and DCX
To further characterize the expression of neuronal markers, microtubule-associated protein 2 
(MAP2) and doublecortin (DCX) expression was characterized in separate specimens. All MAP2 
and DCX positive cells were also positive for β-III tubulin. A high rate of cells were MAP2 positive 
(60 % ± 7 %; Figure 12)  and DCX positive (70 % ± 4 %; Figure 12), indicating ongoing neuronal 
development (Figure 12). Out of the β-III tubulin positive cells, 60 % ± 5 % (Figure 12) co-expressed 
MAP2 and 50 % ± 4 %  (Figure 12)  co-expressed DCX.
Figure 11. (A-D) Dissociated HNPC sphere culture on a Matrigel® coated coverslip. Shown here are 
examples of cells expressing β-III tubulin (Red), GFAP (Green), DAPI (Blue) markers. The DAPI-positive 
profiles indicate an intact nuclei morphology. Scale bar = 100 µm.
Figure 12. Expression of the neuronal markers MAP2 and DCX, and their co-expression with β-III 
tubulin in HNPC dissociated sphere cultures (DSC) on Matrigel® (MG) coated coverslips. 
Out of the total number of surviving cells, 60 % ± 7 % were MAP2 positive and 70 % ± 4 % expressed DCX. 
All MAP2 and DCX positive cells were also positive for β-III tubulin. Out of the β-III tubulin positive cells, many 
co-expressed MAP2 (60% ± 5 %) and DCX (50 % ± 4 %). In the control group (not cultured on Matrigel® 
coated coverslips) there was no differentiation observed (here survival was close to zero; Figure 9). 
* indicates p < 0.05.
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Expression of synaptic markers
The synaptic markers synapsin and SV2 were used to determine whether the DSCs on Matrigel® 
coated coverslips also developed a capability to form neuronal connections. Since all HNPCs 
acquiring a neuronal fate were β-III tubulin positive, the co-expression of the anti β-III antibody 
and synapsin or SV2 markers were used to further explore their profiles. The results illustrate that 
80 % ± 9 % (Figure 13) of the β-III tubulin positive profiles were also positive for synapsin and 
62 % ± 4 %  (Figure 13) were also positive for SV2.
Figure 13. Co-expression of β-III tubulin and synapsin or SV2 in HNPC dissociated sphere cultures 
(DSC) on Matrigel® (MG) coated coverslips.
To explore developing contact capabilities in HNPCs, co-expression of the neuronal marker β-III tubulin 
and SV2 or Synapsin was evaluated in DSC on Matrigel® (MG) coated or MG uncoated coverslips. In the 
control group (that was not cultured on Matrigel® coverslips), there was no positive markers observed (sin-
ce survival was close to zero; Figure 9). * indicates p < 0.05.
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Paper III
Here, studies on cell survival after transplantation in vitro were performed. NES cells were cultured 
in a setup with three groups. The first group consisted of NES cells without further manipulation. 
The second and third groups consisted of NES cells that were left to differentiate into neuroblasts 
and NVM (Figure 14). The recording and analyses of differentiation characteristics of a large number 
of cells (> 410 000) as according to immunocytochemical marker stainings were executed after 19 
days of culture.
Survival of seeded specimens
Following 19 days of culture, 77 % of NES cell specimens seeded in the control group displayed 
intact cell profiles (27 out of 35; Figure 14) versus 79 % (38 out of 48; Figure 14) of specimens seeded 
in the experiment group. In the neuroblast group only 20 % (6/30; Figure 14) persisted in control group, 
versus 78 % (29/37; Figure 14) in the experiment group. The groups with cultured NVM displayed a 
severely limited number of cells with intact nuclear profiles. Although, as judged per specimen 
survival the rate in both groups was 50 % (1/2 in control group; 4/8 in experiment group; Figure 14).
Figure 14. Schematics of experimental setup using neuroepithelial-like stem (NES) cells to evalu-
ate the cell survival rate after transplantation to monoculture and a co-culture setup with BS sli-
ce. Three groups of NES cells with different differentiation status was used. Undifferentiated NES cells, 
Neuroblasts and neurons of various maturity (NVM). The control groups was seeded as monocultures. In 
the experiment groups the cells were seeded together with a rat auditory brainstem (BS) slice. The number 
of cultures with surviving cells out the number of seeded cultures is shown for each group (in brackets). 
Bright-field pictures of cells in culture prior to dissociation are shown on the left (a-c).
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Migration
The characteristic profiles of cells displaying elongated nuclei, as a sign of migration, were only 
observed in the NES experiment group. Here it reflected a targeted attraction toward the BS slice.
Axon morphology
In the NES control group, 55 % (Figure 15) of analyzed cells displayed nestin-expressing proces-
ses. These were mostly comprised of primitive, thick, short and irregular branches. In the NES 
experiment group, the number of cells positive for nestin staining was higher (74 %, Figure 15) revea-
ling long thin processes, branched into large networks. Some of the processes was bearing vesicular 
dilations and displaying an organized morphology reflecting neuronal integrity. In both NES control and 
experiment groups, developing neuronal cells positive for TUJ1 (β-III tubulin) had slim, round 
or spindle-shaped cell bodies with mostly one leading process and many smaller multi-branched 
processes. These are all features of cells acquiring neuronal competence.
In the neuroblast control group some mature cells displayed long leading processes,
but the NF positive axons detected were sparse and short. In the neuroblast experiment group, 
NF heavy chain marker staining revealed a complex disorganized network of multi-branched nerve 
cells in 100 % of the specimen tested. Neurites also displayed vesicular dilations reflecting possible 
ongoing axonal transport.
The NVM groups were not analyzed in respect to the development of neural competence as revealed 
by marker staining due to low number of intact cell profiles.
Figure 15. Percentage of cell profiles positive for proliferation and neural stem cell markers in 
the control and experiment groups. Cell profiles were stained for the markers nestin, Ki67, SOX2 
and Musashi. All nuclear profiles were identified with a DAPI/human nuclei marker. Recorded pictures 
taken from representative areas of the specimens were analyzed using CellProfiler and CellProfiler Analyst 
software (mean ± S.E.M.).
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NES cell differentiation following 19 days of culture
Analyses of both the NES control and experiment groups revealed two distinct populations of 
differentiating cells. These were either less mature nestin and SOX2 positive cells, or had started to 
differentiate down a neuronal lineage into more mature cells expressing TUJ1 (β-III tubulin), MAP2 
and DCX.
The less mature nestin positive cells were more common in the periphery illustrating limited differen-
tiation. The SOX2 and nestin markers were predominately co-expressed in all cultured cells.
Almost all mature cells were situated in the center of the seeded cell population (control groups) or 
adjacent to the explant (experiment groups). Double staining with DCX and MAP2 revealed a predo-
minant co-expression in all groups.
The proliferation marker Ki67 showed scattered chromatin bundles in 25 % (Figure 15) of the nuclei 
in the control group, and in 44 % (Figure 15) of the cells in the experiment group. This indicates that 
cells were still undergoing division as a sign of persistent immature traits.
The Musashi staining in the control group (60 %; Figure 15) and the experiment group (96 %; Figure 
15) was noted to be strong in the cytoplasm of the more primitive cells devoid of neuronal processes. 
The Musashi expression was stronger in cells located in the middle of the seeded cell specimens, 
indicating a less differentiated state. However, at the same time it was also noticed that markers for 
more mature neuronal characteristics, such as MAP2 and DCX, were mostly expressed in the same 
location. These cells however, were visibly not the same as the Musashi positive cells (Figure 16). 
This could suggest an ongoing cross talk between cells, indicating that they are depending on signals 
from neighboring cells to differentiate further.
 A very small number of NES cells were SSEA-1 or GFAP positive in any group (< 1 %).
The marker NeuN was expressed in 31 % (Figure 17) of cells in both NES control and experiment 
groups. These cells were also mostly positive for β-III tubulin.
Figure 16. Merged picture of Musashi, DCX 
and DAPI positive cell profiles in NES expe-
riment group. Illustration of low co-expression 
by SC markers Musashi and DCX in culture 
specimen. DAPI positive cell nuclei.
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Figure 17. Percentage of cell profiles positive for neuronal markers in the control and experiment 
groups. Cell profiles were stained for TUJ1 (β-III tubulin), MAP2, NeuN and DCX markers. All nuclear pro-
files were identified with a DAPI/human nuclei marker. Recorded pictures taken from representative areas 
of the specimens were analyzed using CellProfiler and CellProfiler Analyst softwares (mean ± S.E.M.).
Neuroblast differentiation following 19 days of culture
The neuroblasts in the control group developed an extensive network of long TUJ1 (β-III tubulin) 
positive processes (86 %; Figure 17), most of which were double stained for the marker NeuN. No 
MAP2 staining was observed and few cells were DCX positive (36 %, Figure 17). Staining with DCX 
and Musashi antibodies revealed two distinct populations of different cell maturity, as previously also 
noted in the NES culture groups. In this group, as in the NES groups, Ki67 staining was detected in 
33 % (Figure 15) of the cells showing ongoing division.
In the neuroblast experiment group cultured with a BS slice, nestin staining (65 %; Figure 15) 
revealed processes with long fine branches bearing vesicular dilations. Nestin positive processes 
displayed organized morphological formations reflecting neuronal integrity of the cultured cells. 
TUJ1 (β-III tubulin) positive cells formed extensive branched networks of long processes. Extensive 
NeuN expression was detected in 47 % (Figure 17) of the cells and all NeuN positive cells were also 
TUJ1 (β-III tubulin) positive, whereas some of the TUJ1 (β-III tubulin) positive cells did not express 
NeuN. Staining with the proliferation marker Ki67 revealed a small population of still dividing cells 
(30 %; Figure 15). A total of 78 % (Figure 15) of cells were SOX2 positive and 91 % (Figure 15) of 
the cells were positive for Musashi.
NVM differentiation following 19 days of culture
In the NVM experiment group, only a limited number cells displaying intact nuclear profiles were 
detected and in the control group there were even less. The produced specimens in the experiment 
group were analyzed but the results are not included here due to the lack of sufficient controls.
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Paper IV
Here, cultured BS slices were subjected to electrophysiological evaluation with MEA technique.
Prior to recording the electrical activity on a MEA plate, the specimens had been cultured for 21 days 
as interface-cultures on semi-permeable membranes ad modum Stoppini (Stoppini et al., 1991). Out 
of the 44 cultured and recorded specimens, 34 did not produce any spontaneous activity that could be 
detected in this experimental setting. 10 specimens (23 %) generated spontaneous activity that was 
recorded for further analyses. Only basic analyses of the recorded electrical activity were performed 
within the scope of this paper. Focus were put on identifying spontaneous spikes (extracellular corre-
late of action potentials), groups of these spikes (bursts) and the inter-spike intervals.
In specimens with detectable spontaneous activity, data were typically recorded from the start of the 
recording and for another 5 minutes. In some cases, there were still activity to be recorded after 15 
minutes. One specimen was still displaying detectable spikes and groups of spikes at the end of the 
planned recording time of 30 minutes. The detected activity were most often of various amplitude 
and with a different number of spikes per burst. This also varied between evaluated electrodes and 
between samples (Figure 18). The overall characteristics though, were in agreement with previously 
published spontaneous activity-patterns of cerebral cortex (Maeda et al., 1995).
Figure 18. Representative screenshots of recorded spontaneous spiking activity in a neonatal P9 
mouse auditory brainstem slice on MEA plate. Recurrent spontaneous spikes and bursts were obser-
ved. Here, recordings from three time-intervals of two separate electrodes are illustrated for representative 
visualization (A: 0:30 min – 0:39 min; B: 1:30 min – 1:39 min and C: 2:30 min – 2:39 min). These electrodes 
(1: A1-C1, and 2: A2-C2) are located in separate areas of the BS specimen and is presented with traces 
(top) and a corresponding inter-spike interval chart (bottom). Analysis were done with MC Channel Suite 
(MCS).
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DISCUSSION AND FUTURE PERSPECTIVES
This thesis presents four papers with novel results on cell performance in vitro. A selected set of para-
meters where explored to aid the development of future evaluations into cell transplantation in  vitro. 
It contributes to our basic knowledge of how cells behave and how our manipulations affect them in 
culture.
Trophic support by conditioned medium (Paper I)
The trophic support of neurotrophins is essential to the successful culture of neuronal cells. To provi-
de a trophic support by adding a CM, collected from the same type of cells as used in the experiment, 
is a well-established strategy. The positive effect of a BS CM on HNPC survival and differentiation 
reported here is conclusive. Hence, we have good reasons to explore the use of BS CM further in 
future experimental settings.
This does not conclude that the utilized protocol is optimal. It is quite possible that the concentra-
tion of trophic support achieved here is still not high enough, and that an increased concentration is 
favourable for enhanced cell performance. On the other hand, concentration used could already be a 
little too high, with no further enhanced performance achievable, or even with undocumented adverse 
toxic effects already affecting the cells. The results presented here does not provide a dose-response 
analysis.
We show that the BDNF and GDNF content in BS CM varies with time when sampled consecutively. 
As the used secretome enriched medium usually is collected over time and then pooled, the concen-
tration variations reported here, are effectively evened out. It is enticing to propose a study to evaluate 
if the CM collected at a specific time point is actually more favourable in a specific setting, than the 
pooled collected CM. The analyses of the BS CM of a specific time point that is found to render sub-
stantially favourable results could be performed in the same way as we have shown in Paper I. These 
results could provide clues on how to further improve medium compositions.
Also, analysing the mechanisms responsible for the neurotrophin fluctuations we report, could provi-
de new knowledge regarding cell development that may be useful in future transplantation research.
Trophic support by co-cultured brainstem slice (Papers I, II and III)
A joint conclusion drawn from the results presented here is that the performance of cells is generally 
enhanced when cultured in the presence of a BS slice. But, since we have not studied the details of 
the mechanisms behind these results, we can only speculate on the reasons.
Since there is a natural content of BS secretome in a BS co-culture, it is tempting to reason that the 
effects on cell performance will be similar to that of an added BS CM, at least in character. But, the 
fluctuations of secretome content reported here, adds a factor to this line of thought. We can only 
conclude that there could be differences affecting cell performance. This may have implications on 
future evaluations on how transplanted cells should best be prepared, in co-culture or relying on other 
means of support.
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Another factor that should be taken into consideration is how the distance between the transplanted 
cells and the target organ affect the cell-cell microenvironment of locally excreted neurotrophins. 
When the paracrine stimulation of neighbouring cells is the only contributor, the effect of an altered 
distance could be significant, but probably not so when a BS CM is utilized. The implications may be 
similar to that of elucidating the concentration levels of optimal trophic support.
Trophic support from Corning® Matrigel® (paper II)
We note similar effects of cell performance enhancement from the use of Matrigel® on HNPC 
cultures as we do in BC cell and NES cell cultures utilizing BS CM or BS co-cultures (Papers I and 
III). That is, a marked improvement on cell survival in culture. It is not though, possible to perform an 
in depth comparison between the presented results since many of the key factors were not shared (e.g. 
cell substrate and culture setting). There are also large differences in the composition of neurotrophic 
supporting molecules in the cultures (notably, Matrigel® is devoid of BDNF or GDNF), and the pre-
sence of bioactive molecules in Matrigel® coating adds yet another unknown factor. We conclude that, 
the different cell lines possibly have large dissimilarities in their needs for trophic support and that 
the provided factors were valid for the specific cell type resulting in enhanced performance. Or, the 
results indicate that there are other key factors responsible for the effect that are not discerned here.
Seeding of cells (Paper II)
We know that cells need a certain amount of trophic and mechanical support to survive for any longer 
periods of time in vitro. In paper II, we note that there was a marked low rate of surviving cells in the 
control group despite adequate handling and culture setting. We speculate that the utilized cell line of 
HNPCs were more sensitive to manipulation overall.
The comparatively high number of passages before culture (14-17), in combination with the omitted 
serum and trophic support, may have contributed to the poor survival. This even though 
progenitor cells previously have been shown to be very stable and robust without changes over many 
passages (Falk et al., 2012).
Attraction (Papers I and III)
We noted signs of cell migration towards the co-cultured BS slice in Papers I and III. We speculate 
that the observed targeted migration is triggered and guided by a BDNF and/or GDNF gradient 
excreted by the BS slice. This effect does not seem to be affected by the addition of the BS conditioned 
culture medium, as we see similar results of migration of cells between the BC specimens and the 
BS slice in all different experimental groups of Paper I (i.e. with or without BS secretome supplement). 
This implies that the transplanted cells have a high sensitivity to gradient differences and that these 
gradients are stable. This could be utilized in further studies into direction guided differentiation of 
cells candidates for transplantation.
The use of automated evaluation of 2D material (Paper III)
The evaluation of cell characteristics with immunocytochemistry is a well-established method and 
the number of commercially available markers for the detection of specific molecular elements 
38 39
are ever growing. The quality and effectiveness of the technique makes it easy for any laborato-
ry staff to gather large amounts of data. This can then be analysed with qualitative or quantitative 
methods. The recorded data from micrography can easily accumulate into a material too vast for 
practical manual analyses. Fortunately, the development of methods to perform automatized eva- 
luation is advancing and it is now possible to manage advanced systems with only basic know- 
ledge in computer programming. Here, with the support from Department of Information Technology, 
Uppsala University, we utilized the CellProfiler and CellProfilerAnalyst softwares to analyse cell 
profiles from 100 specimens. After analyses, it resulted in data from more than 410 000 individual cell 
profiles. Even if the total computational time for a modern laptop was less than 100 hours, it was still 
a quite laborious process to produce data of high validity.
It is obvious that the tools used here are powerful and of great help in producing transparent and 
consistent methods for the evaluation of immunocytochemical results. This is a field that is likely to 
be enhanced with the development of artificial intelligence (AI) algorithms. In the software used here 
there are elements of machine learning based on manual analyses of cells to generate rules which are 
later used as a template for evaluation. A software based on AI will likely execute this type of rule 
generation more efficiently and accurately in the near future.
MEA (Paper IV)
We here report of a novel application of the MEA technique to measure the endogenous neural 
activity of cells in interface-culture. This opens up a multitude of new possibilities to study cell 
performance in cultures ad modum Stoppini.
Understanding the distribution of electrical activity in our cultured specimens is crucial for the 
evaluation of integration and function of cells in culture. In addition to the basic parameters we 
report in paper IV, more analyses of first order statistical parameters such as inter-burst interval, mean 
firing rate and the mean bursting rate (Rieke et al., 1997) will provide a even more detailed baseline 
for reference.
There are also new techniques available to perform even more detailed studies on the distribution of 
the electrical activity in specimens. This setting could possibly be expanded to utilize MEA plates 
with a higher density and larger number of electrodes. The high density CMOS-plates now available, 
with an excess of 4000 electrodes distributed on a similar surface area as our 64 electrode plate, could 
present a promising approach to collect much more detailed data for further analyses.
The MEA culture platform is designed for the study of dissociated cells in culture. It would be 
interesting to culture our organotypic cell culture directly on a MEA plate, but the present settings are 
not suitable for culture of thick specimens for long periods due to their limitations in providing tissue 
oxy-genation and nutrition. The introduction of a perforated culture surface with supplementary per-
fusion from below has proven to facilitate oxygenation enough to admit thicker specimens (<400 µm) 
to be cultured and recorded, but still only for a few hours (Gonzalez-Sulser et al., 2011). The addition 
of a rocking culture chamber to increase surface oxygenation has proved effective to enhance tissue 
oxygenation (Panuccio et al., 2018), but the successful culture time is still very limited. We conclude 
that it is still not feasible to perform organotypic cultures for our purposes on a MEA plate with the 
available techniques.
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Cell origin and stage suitable for transplantation (Papers I, II, III and IV)
Availability
Cell substrates available to researchers for in vitro studies of stem and progenitor cells have 
multiplied. Historically the source of these cells were embryonic. The discovery of the totipotent 
and pluripotent cells in the adult mammal increased both the availability and the options for future 
therapeutic protocols for patients. With the introduction of the hiPSC the prospects expanded even 
further. It also ameliorates the immunological and ethical challenges innate to previous transplanta-
tion research.
During the work on this thesis the availability of cells have caused us to shift cell substrates. Initially, 
these were harvested from mouse or rat since these were the most relevant cells available. Now focus 
is entirely on human cells as they have become available. Utilizing human cells is also in line with 
our efforts to bring our in vitro research closer to the patient.
Cells for transplantation
A cell considered for transplantation in vivo is probably not going to be a SC, but rather a cell that 
has developed further into a more specialized state. A developed neuron could qualify as a viable 
candidate in the case of the hearing-impaired patient. Possibly, a neuron that is still differentiating to 
some degree would also be applicable, as such a cell may have a better chance of adapting to a new 
environment than the adult specialized neuron. For a two main reasons, the exact differentiational sta-
te of a proposed cell for transplantation in vivo is recognized as important, i.e. the documented risk of 
induced teratoma formation and the risk of an uncontrolled proliferation. We further show that, when 
assessing essential factors for a cell preparation protocol, the vulnerability of cells to the trauma and 
stress following cell transfer also needs to be considered. 
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CONCLUSIONS
Paper I
Here we report that the levels of the neurotrophic factors BDNF and GDNF are many times higher 
in medium after it has been conditioned with an auditory BS slice. We also note that the levels 
varies depending on the timepoint in culture that was chosen for medium collection. We describe how 
the BS CM positively affects the survival and differentiation characteristics of BC cells in BS slice 
co-culture. We note that the BC cells migrate towards the BS slice as a sign of attraction.
Paper II
Here we demonstrate how a Matrigel® coating of the culture surface positively affects the survival 
rate of dissociated HNPCs. We also report the differentiation characteristics of HNPCs after three 
weeks in this culture setting.
Paper III
Out of the three explored groups in this report (NES cells, neuroblasts and NVM), the less differen- 
tiated cells (i.e. the NES cells) prove to be more resilient to the manipulations involved in the cell 
transplantation process, as compared to the more differentiated cells. Therefore, based on the overall 
survival, the less differentiated cells are likely to be the more suitable choice for cell transplantation. 
The impact and relevance of our extensive evaluation of differentiation characteristics of cells in 
culture is yet to be determined.
Paper IV
Utilizing a modified protocol, the MEA technique can be used to evaluate the endogenous electrical 
activity in a BS slice cultured ad modum Stoppini (interface-culture). It is important to evaluate the 
electrophysical activity of cells in vitro to estimate the feasibility of future cell transplant paradigms, 
especially if this will include the functional integration of the transplanted cells. Here we show that 
the recorded data patterns of spikes, inter-spike intervals and bursts correspond well with previously 
published neuronal recordings. We predict that the method presented here will be explored further in 
future studies.
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POPULÄRVETENSKAPLIG SAMMANFATTNING PÅ SVENSKA
Hörsel är ett av våra fem sinnen. Då världen idag ställer stora krav på kommunikationsförmåga så är 
det lätt att förstå att en skadad hörsel resulterar i ett stort lidande. Hörselnedsättning är dessutom ett 
av de vanligaste handikappen världen över och många studier har även visat att individen upplever 
sitt lidande som betydande.
Historiskt så är förvärvade hörselnedsättningar ofta en följd av infektioner och skador. Tack vara 
antibiotika och modern kirurgi kan vi idag hjälpa många av de som är drabbade. Med modern teknik 
så är det också möjligt att hjälpa många av de som har en gravt nedsatt funktion i själva hörselorganet 
med hjälp av ett implantat till öronsnäckan (cochlea implantat, CI). Idag har vi således viss möjlighet 
att hjälpa patienter även i denna grupp, som tidigare varit och förblivit döva.
Det finns dock fortfarande grupper av hörselskadade patienter som trots alla de landvinningar som 
gjorts in om medicin och teknik, av olika anledningar inte uppnår en god fungerande hörselnivå. 
Det är bland dessa patienter som vi tänker oss att en transplantation av celler till hörselsystemet 
skulle kunna bidra till hörselrehabilitering. Kanske kan dessa celler hjälpa kroppen själv att reparera 
sina skador, eller så kan vi använda dom för att hjälpa till att förbättra kontakten mellan vävnad och 
implantat, och på så sätt förbättra funktionen av existerande hörhjälpmedel.
I denna avhandling utforskar vi möjligheterna att utnyttja och förbättra våra aktuella cellodlings- 
tekniker för att närma oss en verksam metod att transplantera celler till innerörat.
Vi använder genomgående vår etablerade modell för cellodling i laboratorium för att testa hur olika 
celler beter sig under specifika förhållanden. Vår modell går ut på att odla en hjärnstamsskiva på ett 
membran och sedan transplantera cellerna dit. Denna odling pågår under två till tre veckor varefter 
den stoppas och analyseras. Vi mäter hur cellerna har överlevt under de aktuella förhållandena, hur 
dom eventuellt har förflyttat sig i odlingen, hur dem har förändrats och utvecklats, samt om dem visar 
tecken till integration med varandra.
I arbete I så fokuserar vi på att studera den lösning (medium) som cellerna lever i under tiden i 
odling. För att cellerna ska växa och trivas så krävs det inte bara stabila förhållanden och näring utan 
även proteiner som stimulerar tillväxt. Dessa proteiner produceras till största del av cellerna själva 
eller av närliggande celler. Det är komplicerat att producera dessa proteiner varför man gärna samlar 
in och återanvänder de som utsöndras och ansamlas i mediet under odlingen. Vi har använt åter- 
insamlat medium med tillväxtfaktorer (conditioned medium, CM) tidigare med gott resultat. I artikel 
I så analyserar vi innehållet i detta medium på ett sätt som inte tidigare är gjort. Vi noterar att tillväxt-
faktorerna BDNF och GNDF finns i stor mängd i CM, och att koncentrationen varierar beroende på 
när vi samlar in mediet.
En del av arbetet går ut på att utforska olika celltypers lämplighet som underlag i en transplantations-
modell. I arbete I, II och III undersöker vi tre olika typer av omogna celler som efter genomgång av 
aktuellt forskningsläge visat sig varit möjliga transplantationskandidater i detta sammanhang.
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Sedan 60-talet har vi känt till att det finns omogna celler även i den vuxna kroppen. Dessa celler har 
gemensamma egenskaper med de första cellerna som uppstår direkt efter befruktningen. Dessa omog-
na celler är till en början helt identiska med varandra och har kapacitet att utvecklas till vilken cell 
som helst i den framtida organismen. Redan i och med den femte celldelningen så påbörjar cellerna 
dock sin utmognad till olika celltyper i den växande organismen. Ur transplantationssynpunkt så är 
det lockande att skörda de mest omogna cellerna och sedan förmå dem till att bilda exakt de cell- 
typer som man önskar ersätta. Detta har dock visat sig komplicerat, både tekniskt, på grund av immun- 
försvarets motvilja att slutligen acceptera okända celler. Dessutom är de viktiga etiska aspekterna 
nödvändiga att ta med i valet av transplantationskandidater.
Det senaste lovande framstegen vad gäller möjliga kandidater är de inducerade progenitorcellerna 
(iPS celler). Dessa utgår från vanliga celler, exempelvis från patienten själv, som man sedan styr 
tillbaka i utvecklingen så att de återfår sin förmåga att likt omogna celler kunna utvecklas till olika 
celltyper. Under detta arbetes gång så har tillgången till lämpliga celler förändrats. I det första arbetet 
undersöker vi embryonala celler från mus, medan vi i arbete II och III har gått över till att undersöka 
humana celler.
De transplanterade cellerna kommer troligen att behöva förbehandlas innan de transplanteras. I arbete 
I och II visar vi att vår manipulation av den lösning de växer i, samt den justerade behandlingen av 
odlingsytan är positiv för cellöverlevnad.
Arbete IV är ytterligare metodinriktat. För att värdera hur cellerna integreras så är det värdefullt att 
göra en bedömning av deras funktioner. Det visar sig att det inte finns någon etablerad modell för att 
mäta funktionen i den odlingsmodell vi använder. Vi har många gånger värderat förekomsten av viktiga 
faktorer som krävs för att kunna etablera funktionella kontakter mellan cellerna, men aldrig förekom-
sten av de elektriska signalerna som överförs. Här modifierar vi en etablerad teknik bestående av små 
plattor med fixerade elektroder (microelectrode array, MEA) som mäter spänningsskillnaderna och vi 
och kan på så sätt mäta förekomsten av de elektriska signalerna. Våra resultat visar att det går att mäta 
signalerna som uppstår spontant i våra odlingar med denna teknik. Detta öppnar ett helt nytt fält av 
möjliga framtida undersökningar gällande hur väl transplanterade celler integreras med ett konstrue-
rat målorgan i en cellodlingsmodell. 
Det är idag inte tydligt hur transplanterade celler bäst kommer att kunna bidra till hörselrehabili- 
teringen av våra patienter. Det finns två huvudsakliga spår som det forskas mycket kring.
Det ena tar avstamp i kunskapen om cellernas egen förmåga att stimulera reparationen av skadad väv-
nad då en väl etablerad skada i hörselorganen uppvisar en avstannad läkningsprocess. Man har sett 
att omogna celler i vissa fall rekryteras lokalt i vävnad, vilken även sker i den vuxna människan, och 
bidrar till att reparera skadorna. Därför kan man även tänka sig att transplanerade celler framställda 
från stam- eller progenitorceller till ett skadat område kan bidra till att åter starta en konstruktiv läk-
ningsprocess. Det andra spåret för transplanterade celler är att  bidra till att förbättra kontakten mellan 
ett implanterat hörselhjälpmedel och det avsedda målorganet. Detta skulle ske genom att hjälpa till att 
etablera bättre kontakter mellan implantatets stimulerande ytor och målorganet. Om detta kommer att 
ske med hjälp av de transplanterade cellernas förmåga att stimulera cellutveckling lokalt eller genom 
direkt transplantation av rätt celler till rätt plats är ännu oklart.
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Vårt övergripande mål är att bidra med kunskap som förutsäger hur en framtida modell för celltrans-
plantation blir lyckosam. Då mycket fortfarande är oklart har vi lagt mycket tid på att undersöka 
cellernas karakteristika vad gäller omognad och mognad med hjälp av väl etablerade markörer. Detta 
materialet kommer bäst att kunna tolkas i relation till ett tydligt behov, exempelvis i form av en viss 
celltyp som innehar en specifik uppsättning egenskaper. Här bidrar denna doktorsavhandling framför 
allt med en detaljerad beskrivning av hur cellerna beter sig i den undersökta miljön.
Sammanfattningsvis kan sägas att avhandlingen bidrar med ny information som utvecklar våra 
möjligheter att undersöka celler i odling och med ny kunskap om hur de olika cellerna överlever och 
vidareutvecklas. Dessutom ingår vidareutveckling av flera metoder för att analysera dessa transplan-
terade celler. Slutligen hoppas jag att detta i förlängningen kan bidra till att vi kan hjälpa fler hörsel-
skadade patienter att få en fungerande hörsel.
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